Heavy Metal Poisoning Market

DelveInsight’s ‘Heavy Metal Poisoning – Market Insights, Epidemiology, and Market Forecast-2030’ report delivers an in-depth understanding of the disease, historical, and forecasted epidemiology as well as the market trends of Heavy Metal Poisoning in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.


The heavy metal poisoning market report provides analysis regarding current treatment practices, emerging drugs like Emeramide, potential therapies, market share of the individual therapies, and historical, current and forecasted Heavy Metal Poisoning market size from 2017 to 2030, segmented by seven major markets.


The report also covers current heavy metal poisoning treatment practice/algorithm, guidelines, market drivers, market barriers, and unmet medical needs to curate best of the opportunities. It assesses the underlying potential of the market.

Geography Covered

  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan

Study Period: 2017–2030

Heavy Metal Poisoning – Disease Understanding and Treatment Algorithm

Overview

Heavy metal poisoning is the accumulation of heavy metals, in toxic amounts, in the soft tissues of the body. Symptoms and physical findings associated with heavy metal poisoning vary according to the metal accumulated. Many of the heavy metals, such as zinc, copper, chromium, iron and manganese, are essential to body function in very small amounts. But, if these metals accumulate in the body in concentrations sufficient to cause poisoning, then serious damage may occur. The heavy metals most commonly associated with poisoning of humans are lead, mercury, arsenic and cadmium. Heavy metal poisoning may occur as a result of industrial exposure, air or water pollution, foods, medicines, improperly coated food containers, or the ingestion of lead-based paints.


Treatment

The main treatment of heavy metal poisoning is the termination of exposure to the metal. Treatment also consists of the use of various chelating agents that cause the toxic (poison) element to bind with the drug and be excreted in the urine. Three common drugs for the treatment of metal poisoning are BAL (dimercaprol), Calcium EDTA (calcium disodium versenate), and penicillamine. Each of these work by binding actions that permit the metals to be eliminated from the body through the urine.


Treatment should also be symptomatic and supportive. In some cases, the pumping of the stomach (gastric lavage) is used to remove some ingested metals. In the case of inhaled poisons, affected individuals should be removed from the contaminated environment and their respiration supported.


This chapter covers the details of conventional and current medical therapies available for the treatment of heavy metal poisoning. It also provides heavy metal poisoning treatment guidelines across the United States and Europe.


DelveInsight’s Heavy Metal Poisoning market report gives a thorough understanding of the disease by including details such as disease definition, symptoms, types, grading, pathophysiology, and diagnosis. It also provides heavy metal poisoning treatment algorithms and treatment guidelines in the US, Europe, and Japan.

Epidemiology:

The Heavy Metal Poisoning epidemiology chapters provide insights about historical and current heavy metal poisoning patient pool and forecasted trend for every seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. Heavy metal poisoning epidemiology is segmented by total incident cases of heavy metal poisoning by age and by metal type. Besides, the report includes a thorough analysis of all segments.


According to DelveInsight’s analysis, the total prevalent population of heavy metal poisoning in seven major markets was 22,283 in 2020. These cases are expected to increase with a significant CAGR during the study period (2017–2030).


Among all the seven major markets, total prevalent cases for heavy metal poisoning were highest in the United States, followed by Japan. Spain accounted for the least number of prevalent cases among the 7MM.

Drug Chapters:

This segment encloses the detailed analysis of the drugs in the heavy metal poisoning pipeline. It also helps understand the Heavy Metal Poisoning clinical trial details, expressive pharmacological action, agreements of the included drug, and the latest news and press releases.


Currently, the main treatment of heavy metal poisoning is the termination of exposure to the metal. Treatment also consists of the use of various chelating agents that cause the toxic (poison) element to bind with the drug and be excreted in the urine. Trials of novel therapeutic agents are limited by the time taken to reach clinically significant endpoints.

Market Outlook:

The market size of heavy metal poisoning is expected to increase at a significant CAGR during the study period (2017–2030). Among all the seven major markets, the United States accounted for the largest Heavy metal poisoning market size. Among EU5 countries, Germany, in 2017, had the largest market size with USD 19.87 million, while Spain had the smallest market size of USD 2.13 million.

Drugs Uptake:

This section focuses on the rate of uptake of the potential drugs in the Heavy metal poisoning market or expected to get launched in the market during the study period 2017–2030. The analysis covers heavy metal poisoning market uptake by drugs patient uptake by therapies; and sale of each drug.


It helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allows the comparison of the drugs based on market share and size. All of which will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.


Emeramide (Emeramed) is a major player that will alter the market dynamics in the forecasted period 2020–2030.

Heavy metal poisoning: Pipeline Development Activities

The report provides insights into different therapeutic candidates and also analyses the key players involved in developing targeted therapeutics.


Pipeline Development Activities:

The report covers the detailed information of collaborations, acquisition and merger, licensing, patent details, and emerging therapies, concerning heavy metal poisoning.

KOL Views

To keep up with current market trends, we take KOLs and SME’s opinion working in heavy metal poisoning domain through primary research to fill the data gaps and validate our secondary research. It will support the clients in assessing potential upcoming novel treatment by identifying the overall scenario of the market and the unmet needs.

Competitive Intelligence Analysis

We have performed the competitive and market Intelligence analysis of the heavy metal poisoning market by using various competitive intelligence tools that include SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies, etc. Besides, the inclusion of the analysis entirely depends upon the data availability.

Report Highlights:

  • In the coming years, heavy metal poisoning market scenario is expected to experience a positive shift across the 7MM due to a robust pipeline.
  • Our in-depth analysis of the pipeline assets across different stages of development (Phase II and Phase III), different emerging trends and comparative analysis of pipeline products with detailed clinical profiles, launch date along with product development activities will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the research and development activities

Heavy Metal Poisoning Report Insights:

  • Patient Population
  • Therapeutic Approaches
  • Heavy Metal Poisoning Pipeline Analysis
  • Heavy Metal Poisoning Market Size and Trends
  • Market Opportunities
  • Impact of upcoming Therapies

Heavy Metal Poisoning Report Key Strengths:

  • 11-year Forecast
  • 7MM Coverage
  • Heavy Metal Poisoning Epidemiology Segmentation
  • Key Competitors
  • Market Size by Therapies
  • Drugs Uptake

Heavy Metal Poisoning Report Assessment:

  • Pipeline Product Profiles
  • Key Products and Key Players
  • Market Drivers and Barriers

Key Questions

Market Insights:

  • What was the heavy metal poisoning market share (%) distribution in 2020 and how it would look like in 2030?
  • What would be the heavy metal poisoning total market size as well as market size by therapies across the 7MM during the forecast period (2017–2030)?
  • What are the key findings pertaining to the market across 7MM and which country will have the largest heavy metal poisoning market size during the forecast period (2017–2030)?
  • At what CAGR, the heavy metal poisoning market is expected to grow in THE 7MM during the forecast period (2017–2030)?
  • What would be the heavy metal poisoning market outlook across the 7MM during the forecast period (2017–2030)?
  • What would be the heavy metal poisoning market growth till 2030, and what will be the resultant market Size in the year 2030?
  • How would the market drivers, barriers and future opportunities affect the market dynamics and subsequent analysis of the associated trends?


Epidemiology Insights:

  • What are the disease risk, burden and unmet needs of heavy metal poisoning?
  • What is the historical heavy metal poisoning patient pool in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan?
  • What would be the forecasted patient pool of heavy metal poisoning in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan?
  • What will be the growth opportunities in the 7MM concerning the patient population pertaining to heavy metal poisoning?
  • Out of all 7MM countries, which country would have the highest prevalent population of heavy metal poisoning during the forecast period (2017–2030)?
  • At what CAGR the population is expected to grow in the 7MM during the forecast period (2017–2030)?


Current Treatment Scenario, Marketed Drugs and Emerging Therapies:

  • What are the current options for the heavy metal poisoning treatment, along with the approved therapy?
  • What are the current treatment guidelines for the treatment of heavy metal poisoning in the USA, Europe, and Japan?
  • How many companies are developing therapies for the treatment of heavy metal poisoning?
  • How many therapies are developed by each company for heavy metal poisoning?
  • How many are emerging therapies in mid-stage, and late stage of development for heavy metal poisoning treatment?
  • What are the key collaborations (Industry–Industry, Industry–Academia), Mergers and acquisitions, licensing activities related to the heavy metal poisoning therapies?
  • What are the recent novel therapies, targets, mechanisms of action and technologies developed to overcome the limitation of existing therapies?
  • What are the clinical studies going on for heavy metal poisoning and their status?
  • What are the key designations that have been granted for the emerging therapies for heavy metal poisoning?
  • What is the global historical and forecasted market of heavy metal poisoning?

Reasons to buy:

  • The report will help in developing business strategies by understanding trends shaping and driving the heavy metal poisoning market
  • To understand the future market competition in the heavy metal poisoning market and Insightful review of the key market drivers and barriers
  • Organize sales and marketing efforts by identifying the best opportunities for heavy metal poisoning in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom) and Japan
  • Identification of strong upcoming players in the market will help in devising strategies that will help in getting ahead of competitors
  • Organize sales and marketing efforts by identifying the best opportunities for heavy metal poisoning market
  • To understand the future market competition in the Heavy Metal Poisoning market


Which geography accounted for the largest heavy metal poisoning market size?

The United States accounted for the largest heavy metal poisoning market size.


What is the forecasted Heavy Metal Poisoning market size in 2030?

DelveInsight estimates an increase in heavy metal poisoning market size during the study period, 2017–2030.


What are the present, heavy metal poisoning market drivers?

Targeting of Novel Pathways, Rising Investigations, Availability of Clear Diagnostics and Increasing Industrialization.


What are the heavy metal poisoning market barriers?

Standardized Treatment Routine, Rising Exposure Control Measures, Carcinogenic Risk and Irreversible Damage.


How many companies are developing drugs for Heavy Metal Poisoning?

Currently, key pharma players are developing the drug for heavy metal poisoning.


Which are the leading companies in the heavy metal poisoning market?

Key Players – Emeramed


How is epidemiology segmented for heavy metal poisoning?

It is segmented into total incident cases of heavy metal poisoning, age-specific cases of Heavy Metal Poisoning, and cases of heavy metal poisoning by metal type.

1. Key Insights

2. Executive Summary of Heavy Metal Poisoning

3. Heavy Metal Poisoning Market Overview at a Glance

3.1. Market Share (%) Distribution of Heavy Metal Poisoning in 2020

3.2. Market Share (%) Distribution of Heavy Metal Poisoning in 2030

4. Disease Background and Overview

4.1. Introduction

4.2. Symptoms

4.3. Heavy Metal Poisoning Causes and Risk Factors

4.4. Subdivisions of Heavy Metal Poisoning

4.4.1. Lead Poisoning

4.4.2. Mercury Poisoning

4.4.3. Arsenic Poisoning

4.4.4. Cadmium Poisoning

4.4.5. Other Metals

4.4.5.1 Chromium poisoning

4.4.5.2. Uranium Poisoning

4.4.5.3. Gadolinium Poisoning

4.5. Diagnosis

4.5.1. Diagnosis of Lead Poisoning

4.5.2. Diagnosis of Mercury Poisoning

4.5.3. Diagnosis of Arsenic Poisoning

4.5.4. Diagnosis of Cadmium Poisoning

4.5.5. Diagnosis of Chromium poisoning

5. Epidemiology and Patient Population

5.1. Key Findings

6. 7MM Epidemiology

6.1. Total Heavy Metal Poisoning cases in the 7MM

6.2. Assumptions and rationale

6.3. The United States

6.3.1. Total Heavy Metal Poisoning cases in the United States

6.3.2. Age-specific cases of Heavy Metal Poisoning in the United States

6.3.3. Heavy Metal Poisoning cases by metal type in the United States

6.4. EU5 Countries

6.4.1. Germany

6.4.1.1. Total Heavy Metal Poisoning cases in Germany

6.4.1.2. Age-specific cases of Heavy Metal Poisoning by Symptoms in Germany

6.4.1.3. Heavy Metal Poisoning cases by metal type in Germany

6.4.2. France

6.4.2.1. Total Heavy Metal Poisoning cases in France

6.4.2.2. Age-specific cases of Heavy Metal Poisoning by Symptoms in France

6.4.2.3. Heavy Metal Poisoning cases by metal type in France

6.4.3. Italy

6.4.3.1. Total Heavy Metal Poisoning cases in Italy

6.4.3.2. Age-specific cases of Heavy Metal Poisoning by Symptoms in Italy

6.4.3.3. Heavy Metal Poisoning cases by metal type in Italy

6.4.4. Spain

6.4.4.1. Total Heavy Metal Poisoning cases in Spain

6.4.4.2. Age-specific cases of Heavy Metal Poisoning by Symptoms in Spain

6.4.4.3. Heavy Metal Poisoning cases by metal type in Spain

6.4.5. United Kingdom

6.4.5.1. Total Heavy Metal Poisoning cases in the UK

6.4.5.2. Age-specific cases of Heavy Metal Poisoning by Symptoms in the UK

6.4.5.3. Heavy Metal Poisoning cases by metal type in the UK

6.5. Japan

6.5.1. Total Heavy Metal Poisoning cases in the Japan

6.5.2. Age-specific cases of Heavy Metal Poisoning in Japan

6.5.3. Heavy Metal Poisoning cases by metal type in Japan

7. Treatment and Management

7.1. Treatment for Lead poisoning

7.2. Treatment for Arsenic Poisoning

7.3. Treatment of Mercury Poisoning

7.4. Treatment for Cadmium Poisoning

7.5. Treatment for Chromium Poisoning

8. Unmet Needs

9. Organizations contributing toward Heavy Metal Poisoning

10. Case studies

10.1. An Enigmatic Case of Acute Mercury Poisoning: Clinical, Immunological Findings and Platelet Functions

10.2. Multimodal Elimination for Intoxication with a Lethal Dose of Organic Mercury

10.3. A Case of Mercury Toxicity Complicated by Acute Inflammatory Demyelinating Polyneuropathy

10.4. Potential arsenic toxicosis secondary to a herbal kelp supplement

10.5. A case report of adult lead toxicity following the use of Ayurvedic herbal medication

11. KOL Views

12. Patient Journey

13. Emerging Therapies

13.1. Emeramide: Emeramed

13.1.1. Product Description

13.1.2. Other Development Activities

13.1.3. Clinical Development

13.1.3.1. Clinical Trials Information

13.1.4. Safety and Efficacy

14. Heavy Metal Poisoning: Seven Major Market Analysis

14.1. Key Findings

14.2. Market Size of Heavy Metal Poisoning in 7MM

15. Seven Major Market Outlook

15.1. The United States Market Size

15.1.1. Total Market Size of Heavy Metal Poisoning in the United States

15.1.2. Total Market Size of Heavy Metal Poisoning by Therapies in the United States

15.2. Germany

15.2.1. The total market size of Heavy Metal Poisoning in Germany

15.2.2. Market size of Heavy Metal Poisoning by Therapies in Germany

15.3. France

15.3.1. The total market size of Heavy Metal Poisoning in France

15.3.2. Market size of Heavy Metal Poisoning by Therapies in France

15.4. Italy

15.4.1. The total market size of Heavy Metal Poisoning in Italy

15.4.2. Market size of Heavy Metal Poisoning by Therapies in Italy

15.5. Spain

15.5.1. Total Market Size of Heavy Metal Poisoning in Spain

15.5.2. Market size of Heavy Metal Poisoning by Therapies in Spain

15.6. United Kingdom

15.6.1. The total market size of Heavy Metal Poisoning in the United Kingdom

15.6.2. Market size of Heavy Metal Poisoning by Therapies in the UK

15.7. Japan

15.7.1. The total market size of Heavy Metal Poisoning in Japan

15.7.2. Market size of Heavy Metal Poisoning by Therapies in Japan

16. Market Drivers

17. Market Barriers

18. SWOT Analysis for Heavy Metal Poisoning

19. Reimbursement

19.1. Reimbursement of Lead Poisoning Services by Illinois Department of Public Health (IDPH)

19.2. Medicaid Reimbursement for Childhood Lead Poisoning Services

19.3. Case Studies in Healthcare Financing of Healthy Homes Services: Medicaid Reimbursement for Lead Follow-Up Services in Ohio

19.4. Using Medicaid Reimbursement for Childhood Lead Poisoning Case Management and Inspection in Rhode Island

20. Appendix

20.1. Report Methodology

20.2. References

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight

List of Table

Table 1: Summary of Heavy Metal Poisoning Market, Epidemiology, and Key Events (2017–2030)

Table 2: CDC Treatment Recommendations Based on BLL (Blood Lead Level)

Table 3: Total Heavy Metal Poisoning cases in 7MM (2017–2030)

Table 4: Total Heavy Metal Poisoning in the United States (2017–2030)

Table 5: Age-specific cases of Heavy Metal Poisoning in the US (2017–2030)

Table 6: Heavy Metal Poisoning cases by metal type in the US (2017–2030)

Table 7: Total Heavy Metal Poisoning in Germany (2017–2030)

Table 8: Age-specific cases of Heavy Metal Poisoning in Germany (2017–2030)

Table 9: Heavy Metal Poisoning cases by metal type in Germany (2017–2030)

Table 10: Total Heavy Metal Poisoning in France (2017–2030)

Table 11: Age-specific cases of Heavy Metal Poisoning in France (2017–2030)

Table 12: Heavy Metal Poisoning cases by metal type in France (2017–2030)

Table 13: Total Heavy Metal Poisoning in Italy (2017–2030)

Table 14: Age-specific cases of Heavy Metal Poisoning in Italy (2017–2030)

Table 15: Heavy Metal Poisoning cases by metal type in Italy (2017–2030)

Table 16: Total Heavy Metal Poisoning in Spain (2017–2030)

Table 17: Age-specific cases of Heavy Metal Poisoning in Spain (2017–2030)

Table 18: Heavy Metal Poisoning cases by metal type in Spain (2017–2030)

Table 19: Total Heavy Metal Poisoning in the UK (2017–2030)

Table 20: Age-specific cases of Heavy Metal Poisoning in the UK (2017–2030)

Table 21: Heavy Metal Poisoning cases by metal type in the UK (2017–2030)

Table 22: Total Heavy Metal Poisoning in Japan (2017–2030)

Table 23: Age-specific cases of Heavy Metal Poisoning in the US (2017–2030)

Table 24: Heavy Metal Poisoning cases by metal type in Japan (2017–2030)

Table 25: Overview of chelation drugs

Table 26: Emeramide, Clinical Trial Description, 2020

Table 27: Market Size of Heavy Metal Poisoning in 7MM in USD Million (2017–2030)

Table 28: The US Market Size of Heavy Metal Poisoning in USD Million (2017–2030)

Table 29: US Market Size of Heavy Metal Poisoning in USD Million (2017–2030)

Table 30: Market Size of Heavy Metal Poisoning in Germany, USD Millions (2017–2030)

Table 31: Germany Market Size of Heavy Metal Poisoning by Therapies in USD Million (2017–2030)

Table 32: Market Size of Heavy Metal Poisoning associated in France, USD Millions (2017–2030)

Table 33: France Market Size of Heavy Metal Poisoning by Therapies in USD Million (2017–2030)

Table 34: Italy Market Size of Heavy Metal Poisoning by Therapies in USD Million (2017–2030)

Table 35: Italy Market Size of Heavy Metal Poisoning by Therapies in USD Million (2017–2030)

Table 36: Market Size of Heavy Metal Poisoning in Spain, USD Millions (2017–2030)

Table 37: Spain Market Size of Heavy Metal Poisoning by Therapies in USD Million (2017–2030)

Table 38: Market Size of Heavy Metal Poisoning in the UK, USD Millions (2017–2030)

Table 39: UK Market Size of Heavy Metal Poisoning by Therapies in USD Million (2017–2030)

Table 40: Market Size of Heavy Metal Poisoning in Japan, USD Millions (2017–2030)

Table 41: Japan Market Size of Heavy Metal Poisoning by Therapies in USD Million (2017–2030)

List of Figures

Figure 1: A relative contribution of different sources to human cadmium exposure

Figure 2: Values of cadmium toxicity

Figure 3: Various sources of lead pollution in the environment

Figure 4: The increase in blood lead concentration affecting a person’s IQ

Figure 5: Effects of increased lead level in the blood

Figure 6: Uranium Exposure Pathways

Figure 7: Diagnosis Algorithm of Arsenic Poisoning

Figure 8: Total Heavy Metal Poisoning cases in 7MM (2017–2030)

Figure 9: Total Heavy Metal Poisoning in the United States (2017–2030)

Figure 10: Age-specific cases of Heavy Metal Poisoning in the US (2017–2030)

Figure 11: Heavy Metal Poisoning cases by metal type in the US (2017–2030)

Figure 12: Total Heavy Metal Poisoning in Germany (2017–2030)

Figure 13: Age-specific cases of Heavy Metal Poisoning in Germany (2017–2030)

Figure 14: Heavy Metal Poisoning cases by metal type in Germany (2017–2030)

Figure 15: Total Heavy Metal Poisoning in France (2017–2030)

Figure 16: Age-specific cases of Heavy Metal Poisoning in France (2017–2030)

Figure 17: Heavy Metal Poisoning cases by metal type in France (2017–2030)

Figure 18: Total Heavy Metal Poisoning in Italy (2017–2030)

Figure 19: Age-specific cases of Heavy Metal Poisoning in Italy (2017–2030)

Figure 20: Heavy Metal Poisoning cases by metal type in Italy (2017–2030)

Figure 21: Total Heavy Metal Poisoning in Spain (2017–2030)

Figure 22: Age-specific cases of Heavy Metal Poisoning in Spain (2017–2030)

Figure 23: Heavy Metal Poisoning cases by metal type in Spain (2017–2030)

Figure 24: Total Heavy Metal Poisoning in the UK (2017–2030)

Figure 25: Age-specific cases of Heavy Metal Poisoning in the UK (2017–2030)

Figure 26: Heavy Metal Poisoning cases by metal type in the UK (2017–2030)

Figure 27: Total Heavy Metal Poisoning in Japan (2017–2030)

Figure 28: Age-specific cases of Heavy Metal Poisoning in Japan (2017–2030)

Figure 29: Heavy Metal Poisoning cases by metal type in Japan (2017–2030)

Figure 30: Benefits and drawbacks of chelation therapy

Figure 31: Unmet Needs

Figure 32: Market Size of Heavy Metal Poisoning in USD Million (2017–2030)

Figure 33: Market Size of Heavy Metal Poisoning in the US, USD Millions (2017–2030)

Figure 34: Market Size of Heavy Metal Poisoning in the US by therapies, USD Millions (2017–2030)

Figure 35: Market Size of Heavy Metal Poisoning in Germany, USD Millions (2017–2030)

Figure 36: Market Size of Heavy Metal Poisoning in Germany by therapies, USD Millions (2017–2030)

Figure 37: Market Size of Heavy Metal Poisoning in France, USD Millions (2017–2030)

Figure 38: Market Size of Heavy Metal Poisoning in France by therapies, USD Millions (2017–2030)

Figure 39: Market Size of Heavy Metal Poisoning in Italy, USD Millions (2017–2030)

Figure 40: Market Size of Heavy Metal Poisoning in Italy by therapies, USD Millions (2017–2030)

Figure 41: Market Size of Heavy Metal Poisoning in Spain, USD Millions (2017–2030)

Figure 42: Market Size of Heavy Metal Poisoning in Spain by therapies, USD Millions (2017–2030)

Figure 43: Market Size of Heavy Metal Poisoning in the UK, USD Millions (2017–2030)

Figure 44: Market Size of Heavy Metal Poisoning in the UK by therapies, USD Millions (2017–2030)

Figure 45: Market Size of Heavy Metal Poisoning in Japan, USD Millions (2017–2030)

Figure 46: Market Size of Heavy Metal Poisoning in Japan by therapies, USD Millions (2017–2030)

Figure 47: Market Drivers

Figure 48: Market Barriers

Emeramed

  • Tags:
  • Heavy Metal Poisoning Market
  • Heavy Metal Poisoning Market Size
  • Heavy Metal Poisoning Market Resea...
  • Heavy Metal Poisoning

Forward to Friend

Need A Quote